Disease-modifying therapy

[키워드] acute respiratory syndrome age anti-CD20 association Asymptomatic Case fatality rate caused clinical trial clinical trials cohorts confirmed case coronavirus coronavirus disease COVID-19 COVID-19 cohort COVID-19 patient COVID-19 severity criteria Critical database datasets death diagnosed died Disease-modifying therapy duration of exposure EHR Evidence External Factor General population Health Hospitalization Hospitalized hypertension IgG level Immunoglobulin internal invasive ventilation Male sex Mild moderate Most patient multiple sclerosis number of comorbidity Ocrelizumab outcome Patient patients presence of comorbidity provide real-world data reported SARS-CoV-2 SARS-COV-2 infection serum severe COVID-19 severe disease severe disease course severity treated
[DOI] 10.1016/j.msard.2020.102725 PMC 바로가기 [Article Type] Article